BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 19457631)

  • 21. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.
    Müller-Horvat C; Radny P; Eigentler TK; Schäfer J; Pfannenberg C; Horger M; Khorchidi S; Nägele T; Garbe C; Claussen CD; Schlemmer HP
    Eur J Cancer; 2006 Feb; 42(3):342-50. PubMed ID: 16364631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-body MRI as a screening tool?
    Ladd SC
    Eur J Radiol; 2009 Jun; 70(3):452-62. PubMed ID: 19345540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole body MR imaging: applications in oncology.
    Johnston C; Brennan S; Ford S; Eustace S
    Eur J Surg Oncol; 2006 Apr; 32(3):239-46. PubMed ID: 16427246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of whole body MRI and diffusion-weighted MRI in detecting intranodal lesions in patients with lymphoma].
    Li Z; Hu DY; Xia LM; Feng DY; Peng L; Wang CY; Chu Q
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):695-8. PubMed ID: 19173913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.
    Schmidt GP; Schoenberg SO; Schmid R; Stahl R; Tiling R; Becker CR; Reiser MF; Baur-Melnyk A
    Eur Radiol; 2007 Apr; 17(4):939-49. PubMed ID: 16951929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
    Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body MRI in children: current status and future applications.
    Darge K; Jaramillo D; Siegel MJ
    Eur J Radiol; 2008 Nov; 68(2):289-98. PubMed ID: 18799279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-body MRI in the pediatric patient.
    Ley S; Ley-Zaporozhan J; Schenk JP
    Eur J Radiol; 2009 Jun; 70(3):442-51. PubMed ID: 19329269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloma update.
    Mulligan ME
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
    Garbe C; Eigentler TK
    Melanoma Res; 2007 Apr; 17(2):117-27. PubMed ID: 17496787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging of liver malignancies.
    Ba-Ssalamah A; Fakhrai N; Matzek WK; Herneth AM; Stadler A; Bastati N; Herold CJ; Schima W
    Top Magn Reson Imaging; 2007 Dec; 18(6):445-55. PubMed ID: 18303402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State-of-the-art magnetic resonance imaging of pancreatic cancer.
    Schima W; Ba-Ssalamah A; Goetzinger P; Scharitzer M; Koelblinger C
    Top Magn Reson Imaging; 2007 Dec; 18(6):421-9. PubMed ID: 18303400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted whole-body MR screening.
    Vilanova JC; Barceló J
    Eur J Radiol; 2008 Sep; 67(3):440-7. PubMed ID: 18430538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Magnetic resonance imaging and prostate cancer].
    Cornud F; Villers A; Mongiat-Artus P; Rebillard X; Soulie M;
    Prog Urol; 2008 Nov; 18(10):621-33. PubMed ID: 18971104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fundamental study of the detection of metastatic bone tumors with whole-body MR imaging].
    Iizuka M; Nagai K; Tamada T; Kajihara Y; Fukunaga M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Aug; 59(9):470-2. PubMed ID: 10487060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear magnetic resonance imaging in oncology.
    Frank JA; Dwyer AJ; Doppman JL
    Important Adv Oncol; 1987; ():133-74. PubMed ID: 3331379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Perfusion and diffusion-weighted MR imaging in the early staging and the follow-up of patients with lung cancer].
    Khalil A; Thomassin-Naggara I; Gounant V; Nedelcu N; Marsault C; Carette MF
    Rev Pneumol Clin; 2009 Feb; 65(1):40-8. PubMed ID: 19306784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR imaging in local staging of prostate cancer.
    Fütterer JJ
    Eur J Radiol; 2007 Sep; 63(3):328-34. PubMed ID: 17689908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relevance of magnetic resonance imaging for the staging and follow up of lymph node pathologies in adults with primary malignant lymphomas].
    Michna G; Ghanem N; Laubenberger J; Schneider B; Kromeier J; Langer M
    Radiologe; 2002 Dec; 42(12):993-9. PubMed ID: 12486553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.